Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Martin Fan 's Stock Ratings
Wedbush Analyst
Martin Fan is an analyst at Wedbush. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/19/2025
Overall Average Return
1.74%
Smart Score
Overall Average Return Percentile
40th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/28/2025 | ACRS | Buy Now | Aclaris Therapeutics | $1.40 | 471.35% | Martin Fan 53% | → $8 | Initiates | → Outperform | Get Alert |
| 05/15/2025 | ORKA | Buy Now | Oruka Therapeutics | $12.00 | 233.33% | Martin Fan 53% | $40 → $40 | Reiterates | Outperform → Outperform | Get Alert |
| 05/01/2025 | ANAB | Buy Now | AnaptysBio | $23.50 | 70.21% | Martin Fan 53% | $40 → $40 | Reiterates | Outperform → Outperform | Get Alert |
| 03/25/2025 | ARTV | Buy Now | Artiva Biotherapeutics | $1.74 | 934.72% | Martin Fan 53% | $18 → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 03/20/2025 | ZBIO | Buy Now | Zenas BioPharma | $9.31 | 275.94% | Martin Fan 53% | → $35 | Initiates | → Outperform | Get Alert |
